Impact of antioxidant therapy on natural pregnancy outcomes and semen parameters in infertile men: a systematic review and Meta-analysis of randomized controlled trials
Policy in this area continues to evolve, and staying current with authoritative sources such as KFF, AARP, and CMS will help you provide accurate guidance to patients
Karimi M, Solati N, Amiri M, et al
[33, 34, 35, 36] Mechanism: Typically pre-renal, occurring in the setting of volume depletion from GI losses (nausea, vomiting, diarrhea, reduced oral intake) More frequently seen at higher, obesity-level doses Although generally reno-protective long term, post-marketing data describe acute rises in creatinine following days to weeks of significant GI symptoms Risk factors: Underlying chronic kidney disease Concomitant use of ACE inhibitors, ARBs, diuretics, or SGLT2 inhibitors ED Management: IV fluids Hold GLP-1 and contributing medications Usually reversible with supportive care Future Directions GLP-1 receptor agonists are rapidly evolving beyond their original indications in diabetes and obesity
